Cyclomics is a Dutch startup, founded by scientists of the UMC Utrecht, with the ambition to revolutionize cancer diagnostics and treatment monitoring.
Oxford Nanopore Technologies and @Cyclomics today announced that ‘developer access’ of a new research method has started: the world’s first nanopore sequencing-based solution for ultra-sensitive detection of circulating tumour DNA (ctDNA). Read here: bit.ly/3Z18sAM 1/4